Discovery of novel melatonin-mydroxyquinoline hybrids as multitarget strategies for Alzheimer's disease therapy. Alzforum, 03 May 2024 Wang W, Pan T, Su R, Chen M, Xiong W, Xu C, Huang L. Front Chem. 2024;12:1374930.